Antonios Chatzigeorgiou

6.4k total citations · 1 hit paper
93 papers, 3.1k citations indexed

About

Antonios Chatzigeorgiou is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Antonios Chatzigeorgiou has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 24 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Antonios Chatzigeorgiou's work include Liver Disease Diagnosis and Treatment (23 papers), Adipose Tissue and Metabolism (14 papers) and Adipokines, Inflammation, and Metabolic Diseases (14 papers). Antonios Chatzigeorgiou is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Adipose Tissue and Metabolism (14 papers) and Adipokines, Inflammation, and Metabolic Diseases (14 papers). Antonios Chatzigeorgiou collaborates with scholars based in Greece, Germany and United States. Antonios Chatzigeorgiou's co-authors include Triantafyllos Chavakis, Michael Koutsilieris, Elli F. Kamper, Stefan R. Bornstein, Eleni Kandaraki, Evanthia Diamanti‐Kandarakis, Antonios Halapas, Konstantinos Kalafatakis, Katia Karalis and Lampros Chrysavgis and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Antonios Chatzigeorgiou

85 papers receiving 3.1k citations

Hit Papers

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Diseas... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
    2021 234 citations Narjes Nasiri‐Ansari, Ioannis Kyrou et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios Chatzigeorgiou Greece 32 1.1k 712 699 580 523 93 3.1k
Thomas Illig Germany 31 581 0.5× 806 1.1× 574 0.8× 554 1.0× 386 0.7× 56 3.3k
Hiroshi Saitō Japan 32 730 0.6× 742 1.0× 508 0.7× 364 0.6× 649 1.2× 109 3.2k
Hyun Jin Kim South Korea 29 715 0.6× 1.3k 1.8× 757 1.1× 540 0.9× 517 1.0× 166 3.3k
Daniel T. Meier Switzerland 20 668 0.6× 858 1.2× 643 0.9× 447 0.8× 671 1.3× 41 2.8k
Dan Xu China 34 572 0.5× 1.5k 2.1× 510 0.7× 451 0.8× 357 0.7× 136 4.0k
Afia Naaz United States 11 1.8k 1.6× 841 1.2× 1.4k 1.9× 1.2k 2.1× 600 1.1× 11 4.3k
Gregory Alexander Raciti Italy 26 977 0.9× 1.2k 1.7× 1.2k 1.7× 244 0.4× 431 0.8× 51 3.3k
Feng Zheng China 38 386 0.3× 1.1k 1.5× 579 0.8× 292 0.5× 833 1.6× 74 3.6k
Laura J. den Hartigh United States 20 663 0.6× 635 0.9× 836 1.2× 220 0.4× 271 0.5× 38 2.1k
David Patsouris United States 23 1.4k 1.3× 1.4k 1.9× 1.3k 1.8× 500 0.9× 327 0.6× 30 3.2k

Countries citing papers authored by Antonios Chatzigeorgiou

Since Specialization
Citations

This map shows the geographic impact of Antonios Chatzigeorgiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios Chatzigeorgiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios Chatzigeorgiou more than expected).

Fields of papers citing papers by Antonios Chatzigeorgiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios Chatzigeorgiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios Chatzigeorgiou. The network helps show where Antonios Chatzigeorgiou may publish in the future.

Co-authorship network of co-authors of Antonios Chatzigeorgiou

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios Chatzigeorgiou. A scholar is included among the top collaborators of Antonios Chatzigeorgiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios Chatzigeorgiou. Antonios Chatzigeorgiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chondrogianni, Maria, Ioannis Kyrou, Christina‐Maria Flessa, et al.. (2025). Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies. International Journal of Molecular Sciences. 26(4). 1589–1589. 6 indexed citations
2.
Vlachogiannis, Nikolaos I., Eva Kassi, Petros P. Sfikakis, et al.. (2025). Stabilin-1 levels are related to dysregulated lipid metabolism and atherosclerotic plaque burden. American Journal of Physiology-Heart and Circulatory Physiology. 329(6). H1738–H1744.
3.
Katsarou, Angeliki, George Agrogiannis, Dimitris Veroutis, et al.. (2025). Exercise mitigates liver senescence but does not outmatch dietary restriction in obesity-related MASLD. Metabolism. 170. 156325–156325.
4.
Papadakos, Stavros P., et al.. (2025). Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery. Expert Opinion on Drug Discovery. 20(12). 1683–1700.
5.
Pateras, Ioannis S., Ana Igea, Ilias P. Nikas, et al.. (2024). Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. International Journal of Molecular Sciences. 25(2). 1251–1251. 4 indexed citations
6.
7.
Chung, Kyoung‐Jin, et al.. (2023). Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice. International Journal of Molecular Sciences. 24(5). 4813–4813. 4 indexed citations
8.
Nikolakopoulou, Polyxeni, et al.. (2023). Liver endothelial cells in NAFLD and transition to NASH and HCC. Cellular and Molecular Life Sciences. 80(11). 314–314. 32 indexed citations
9.
10.
Nezos, Adrianos, et al.. (2022). Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome. Journal of Clinical Medicine. 11(5). 1180–1180. 2 indexed citations
11.
Flessa, Christina‐Maria, Narjes Nasiri‐Ansari, Ioannis Kyrou, et al.. (2022). Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. International Journal of Molecular Sciences. 23(24). 15791–15791. 64 indexed citations
12.
Chatzigeorgiou, Antonios, et al.. (2022). Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Current Obesity Reports. 11(3). 126–143. 61 indexed citations
13.
Nasiri‐Ansari, Narjes, Eliana Spilioti, Ioannis Kyrou, et al.. (2022). Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability. International Journal of Molecular Sciences. 23(18). 10960–10960. 8 indexed citations
14.
15.
Κόλλιας, Αναστάσιος, Panagiota Mitrou, Marios K. Georgakis, et al.. (2021). Does Sodium Intake Induce Systemic Inflammatory Response? A Systematic Review and Meta-Analysis of Randomized Studies in Humans. Nutrients. 13(8). 2632–2632. 9 indexed citations
16.
Philippou, Αnastassios, et al.. (2021). Optimizing mechanical stretching protocols for hypertrophic and anti-apoptotic responses in cardiomyocyte-like H9C2 cells. Molecular Biology Reports. 48(1). 645–655. 6 indexed citations
17.
Chatzigeorgiou, Antonios, Lampros Chrysavgis, Peter Lembessis, et al.. (2020). Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Journal of Viral Hepatitis. 28(3). 464–474. 6 indexed citations
18.
Chrysavgis, Lampros, et al.. (2020). The impact of sodium glucose co‐transporter 2 inhibitors on non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 36(4). 893–909. 21 indexed citations
19.
Rahbari, Mohammad, Mathieu Pecqueux, Daniela E. Aust, et al.. (2019). Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes. Journal of Clinical Medicine. 8(5). 696–696. 14 indexed citations
20.
Chatzigeorgiou, Antonios & Triantafyllos Chavakis. (2015). Immune Cells and Metabolism. Handbook of experimental pharmacology. 233. 221–249. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Illig Breakdown of academic impact, for papers by Hiroshi Saitō Breakdown of academic impact, for papers by Hyun Jin Kim Breakdown of academic impact, for papers by Daniel T. Meier Breakdown of academic impact, for papers by Dan Xu Breakdown of academic impact, for papers by Afia Naaz Breakdown of academic impact, for papers by Gregory Alexander Raciti Breakdown of academic impact, for papers by Feng Zheng Breakdown of academic impact, for papers by Laura J. den Hartigh Breakdown of academic impact, for papers by David Patsouris
Rankless by CCL
2026